International Patent: LRRC15-BINDING PROTEINS, MULTISPECIFIC ANTI-LRRC15 X ANTI-TUMOR-ASSOCIATED ANTIGEN (TAA) ANTIBODIES, CONJUGATION LINKERS, AND METHODS OF USE AND PRODUCTION THEREOF

GENEVA, July 9 -- MYTHIC THERAPEUTICS, INC. filed a patent application (US2025/056644) for “LRRC15-BINDING PROTEINS, MULTISPECIFIC ANTI-LRRC15 X ANTI-TUMOR-ASSOCIATED ANTIGEN (TAA) ANTIBODIES, CONJUGATION LINKERS, AND METHODS OF USE AND PRODUCTION THEREOF”. With publication no. WO/2026/112478, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: C07K 16/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....